The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 11, 2015
Filed:
Apr. 13, 2009
Philip Tan, Edmonds, WA (US);
Sandy a Simon, Seattle, WA (US);
Charles G Cerveny, Seattle, WA (US);
Christy Anne Nilsson, Sammamish, WA (US);
William Brady, Bothell, WA (US);
Jeffrey a Ledbetter, Shoreline, WA (US);
Martha S Hayden-ledbetter, Shoreline, WA (US);
Peter a Thompson, Bellevue, WA (US);
Cecile Morales, Seattle, WA (US);
Philip Tan, Edmonds, WA (US);
Sandy A Simon, Seattle, WA (US);
Charles G Cerveny, Seattle, WA (US);
Christy Anne Nilsson, Sammamish, WA (US);
William Brady, Bothell, WA (US);
Jeffrey A Ledbetter, Shoreline, WA (US);
Martha S Hayden-Ledbetter, Shoreline, WA (US);
Peter A Thompson, Bellevue, WA (US);
Cecile Morales, Seattle, WA (US);
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC, Seattle, WA (US);
Abstract
The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases.